Leave Your Message
Tailored active antigens, bio-fermentation intermediates, and micro-crystallization substrates designed for premium pharmaceutical dosage manufacturing.
High-titer, Vero-cell propagated lyophilized formulation with exceptional antibody seroconversion and thermo-stability for post-exposure and pre-exposure prophylaxis.
Explore Specification โ
Homogeneous, customized dry and liquid pre-mix matrices facilitating rapid solubility, uniform distribution of active molecules, and minimal batch variability.
Read More โ
Molecular engineering modifying crystal lattices to enhance the bioavailability, physicochemical stability, and dissolution kinetics of complex active compounds.
Read More โ
Sterile, high-density microbial and fungal fermentations providing ultra-pure proteins, enzymes, and cellular fractions for sophisticated pharmaceutical formulations.
Read More โHow cutting-edge bioprocessing, cold-chain resilience, and targeted macromolecular delivery are reshaping therapeutic and prophylactic vaccine landscapes worldwide.
The global biopharmaceutical industry is experiencing a paradigm shift from conventional whole-pathogen inoculants toward ultra-purified, cell-line-derived immunogens. Cultivating vaccine seed strains in continuous Vero cell substrates drastically diminishes host-cell protein (HCP) contamination and ovalbumin-associated hypersensitivity. When combined with advanced downstream tangential flow filtration (TFF) and chromatography, Vero-cell vaccines provide a reliable foundation for injectable pharmaceutical formulations requiring uncompromising safety profiles.
One of the most persistent bottlenecks in vaccine distribution across emerging economies is cold-chain vulnerability. Freeze-drying (lyophilization) transforms fragile liquid biologicals into solid, amorphous cake matrices using precision cryoprotectants like trehalose and sucrose. This thermal stabilization ensures that critical formulations, such as Freeze-dried Rabies Vaccine For Human Use, preserve over 95% of their antigenic potency under ambient temperature excursions during long-haul transport.
Modern pharmaceutical formulations increasingly demand immune enhancement without elevated reactogenicity. Squalene-based nano-emulsions, plant-derived lipid nanoparticles (LNPs), and micro-emulsified co-crystals serve as potent adjuvants. By optimizing antigen presentation to dendritic cells and toll-like receptors (TLRs), these adjuvant-loaded formulation matrices stimulate robust humoral and cellular mediated immunity with reduced dosage volumes.
Jiangxi Serum Pharma Industries Co., Ltd. is a premier, internationally certified supplier of pharmaceutical and nutritional products in China. For nearly a decade, our enterprise has dedicated itself to exporting high-grade biological products, human vaccines, Western medicines, active pharmaceutical raw materials (APIs), chemical intermediates, sterile medical consumables, food additives, and standardized plant extracts.
By merging sophisticated manufacturing processes with rigorous cGMP compliance and global pharmacopeial standards (USP, EP, BP, CP), we bridge the gap between world-class biotech manufacturing and global clinical accessibility. Our continuous monitoring of market developments has spurred customized development in Pre-Mix formulation, molecular Co-Crystallization, and Bio-Fermentation platforms.
Our comprehensive pharmaceutical catalog consists of human biological products, prophylactic and therapeutic vaccines, Western finished dosages, raw materials, intermediates, and sterile medical consumables. Every batch is manufactured under stringently validated cleanrooms, ensuring endotoxin limits, sterile integrity, and batch-to-batch chemical uniformity.
Whether your project requires high-concentration lyophilized antibody formulations, anti-inflammatory steroid molecules like Dexamethasone Sodium Phosphate, or tailored vaccine active ingredients, Serum Pharma provides comprehensive technical dossiers (DMF, CTD), certificates of analysis (CoA), and regulatory clearance support.
Expanding beyond routine immunization into oncology adjuvants, emergency viral containment, and metabolic therapeutic combinations.
Utilized in emergency rabies exposure regimens and childhood immunization schedules. Freeze-dried Vero-cell vaccines deliver rapid virus-neutralizing antibody (VNA) titers (>0.5 IU/mL) within 7โ14 days, offering dependable safety margins against zoonotic neurotropic viruses.
Active molecules such as Dexamethasone Sodium Phosphate API play a decisive role in mitigating cytokine storms and hyper-inflammatory post-vaccination reactions in vulnerable clinical patient groups, ensuring controlled immune homeostasis.
Cross-disciplinary formulations combining small-molecule GLP-1 receptor agonists with mucosal immunization technologies enable oral and non-invasive therapeutic delivery, eliminating strict fasting and fluid restrictions for end patients.
Our comprehensive nutritional ingredients portfolio spans standardized botanical extracts, cold-pressed plant oils, functional plant proteins, certified probiotic strains (such as Lactobacillus rhamnosus GG / LGG), and high-potency active specialty compounds. We are fully committed to developing evidence-based bioactive ingredients that enhance physical wellness and metabolic vitality.
By applying our cutting-edge bio-fermentation and micro-extraction infrastructure to botanical resources, we provide high-purity, solvent-free plant-derived squalene, polyphenols, and essential bio-lipids that serve dual roles as immune-potentiating adjuvants and premium nutraceutical formulations.
Explore recent technological breakthroughs, market analyses, and therapeutic drug approvals across the global life science arena.
Shark-free, olive-derived and bio-fermented squalene is rapidly overtaking traditional marine sources as the preferred oil-in-water adjuvant for modern influenza, coronavirus, and shingles vaccine formulations, offering 99.5%+ chromatographic purity and carbon-neutral sustainability.
Learn More โ
An in-depth pharmacological evaluation of water-soluble Dexamethasone Sodium Phosphate in emergency resuscitation, acute allergic management, and combination biologic therapy protocols worldwide.
Learn More โ
Revolutionary oral peptide and non-peptide GLP-1 receptor agonist formulations receive expedited regulatory approval, eliminating strict fasting windows, water restrictions, and cold-chain injection burdens for chronic metabolic therapy.
Learn More โExplore our core 8 commercial product and technology categories engineered to meet the highest international pharmacopeia standards.
High-potency, safe immunization formulation with verified antibody titers for reliable human viral prophylaxis.
View Product โ
Precision blend formulations guaranteeing batch consistency for pharmaceutical syrups, injectables, and tablets.
View Product โ
Engineered multi-component crystalline systems optimizing the solubility and stability of poorly soluble drugs.
View Product โ
Microbial fermentation-derived raw materials and biochemical enzymes of the highest pharmaceutical purity.
View Product โ
Ultra-pure botanical lipid emulsion adjuvant tailored for vaccine stability and enhanced immunogenicity.
View Product โ
High-purity USP/EP grade corticosteroid API serving critical anti-inflammatory and immunomodulatory needs.
View Product โ
High-yield synthesis intermediates for modern metabolic regulation and next-generation weight-loss formulations.
View Product โ
Bioactive plant extracts, plant oils, and stabilized probiotics (LGG) maintaining physical balance and gut health.
View Product โJiangxi Serum Pharma Industries Co., Ltd. is your trusted global partner for high-purity vaccines, advanced APIs, and nutritional ingredients.
Contact Us Today
ยฉ 2026 Jiangxi Serum Pharma Industries Co., Ltd. All Rights Reserved. Vaccine For Premium Pharmaceutical Formulations.